'

Advanced Enzymes Technologies conducted conference call on 13 November 2024 to discuss the financial results and performance of the company for the quarter ended September 2024. Mr. Mukund Kabra – Whole-time Director and Mr. Beni Prasad Rauka - Chief Financial Officer along with other senior management of the company addressed the call

Highlights of the Concall

• Revenue from operations on consolidated basis decreased to Rs 146.1 crore in Q2FY25 from Rs 157.8 crore in the Q2FY24, a de-growth of 7%. EBITDA decreased 17% to Rs 42.4 crore while pat de-grew by 5% to Rs 33.4 crore.

• Q2 performance was impacted because of incremental higher revenue reversal of about Rs 8.3 crore as compared to the previous quarter since revenue recognition criteria was not made as per the accounting standard while slowdown in export sales lead to decline in international sales.

• Human nutrition segment revenue decreased by 6% to Rs 99.2 crore in Q2FY25 as com...
  
  
  
  Pleaselogin & subscribe to view the full report.
  
  More Reports
  • 

    (05-Feb-2025)

    Castrol India

    Expects EBITDA margin of 22%-25% for CY25
  • 

    (10-Feb-2023)

    Deepak Nitrite

    Plans capex of about Rs 1500 crore for FY23 and FY24
  • 

    (09-Feb-2023)

    Mayur Uniquoters

    Targets revenue of Rs 1000 crore in FY24
  • 

    (31-Jan-2023)

    Tega industries

    Capex plan is US$ 30-32 million for next three years